All Ernst articles
-
News Real life data reveals success in controlling respiratory syncytial virus
Early data after passive immunisation with a monoclonal antibody against severe respiratory syncytial virus in 2023 show a decline in hospitalisations and length of stay especially in the most vulnerable group of infants under the age of six months.
